Lansforsakringar Fondforvaltning’s ResMed RMD Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$977K	Sell	4,353 -330	-7%	-$82.2K	0.01%	504
2025 Q4	$1.13M	Buy	4,683 +777	+20%	+$199K	0.01%	513
2025 Q3	$1.07M	Sell	3,906 -780	-17%	-$213K	0.01%	503
2025 Q2	$1.21M	Buy	4,686 +953	+26%	+$227K	0.01%	502
2025 Q1	$836K	Buy	3,733 +2,031	+119%	+$474K	0.01%	524
2024 Q4	$389K	Buy	+1,702	New	+$410K	﹤0.01%	535

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lansforsakringar Fondforvaltning's RMD Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning reduced its ResMed (RMD) stake by 7% in Q1 2026, selling an estimated $82.2K and leaving 4,353 shares worth $977K. The position accounts for 0.01% of the portfolio, ranked #504.

Lansforsakringar Fondforvaltning first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.21M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Lansforsakringar Fondforvaltning held 4,353 shares of ResMed worth $977K as of Q1 2026.
Lansforsakringar Fondforvaltning sold 330 ResMed shares in Q1 2026, an estimated $82.2K.
ResMed made up 0.01% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #504 holding.
Lansforsakringar Fondforvaltning first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
Lansforsakringar Fondforvaltning's ResMed position peaked at $1.21M in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.